The dynamic nature of the microbiome is driving momentum and enthusiasm for clinical research. Recent advances in analyzing the microbiome and how it impacts immunity have put our ability to characterize and manipulate the microbiome within reach.
Read More
Medpace and Diversigen discuss the opportunities and challenges of the microbiome in clinical trials in a recently published whitepaper. You can access the whitepaper in its entirety here.
Read More
Recent discoveries have been made that have revealed the power of microbes to prevent, diagnose, and treat disease. As a result of these discoveries, clinical developers are trying to harness these insights in order to develop new medical therapeutics.
Read More